Molecular Composition of Genomic TMPRSS2-ERG Rearrangements in Prostate Cancer

There is increasing interest in the use of cell-free circulating tumor DNA (ctDNA) as a serum marker for therapy assessment in prostate cancer patients. Prostate cancer is characterized by relatively low numbers of mutations, and, in contrast to many other common epithelial cancers, commercially ava...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Dis Markers
Autors principals: Krumbholz, Manuela, Agaimy, Abbas, Stoehr, Robert, Burger, Maximilian, Wach, Sven, Taubert, Helge, Wullich, Bernd, Hartmann, Arndt, Metzler, Markus
Format: Artigo
Idioma:Inglês
Publicat: Hindawi 2019
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6930771/
https://ncbi.nlm.nih.gov/pubmed/31915468
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/5085373
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars